VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Thursday, January 8, 2026
Stock Comparison
AstraZeneca PLC vs Celsius Holdings, Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
AstraZeneca PLC
AZN · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into AstraZeneca PLC's moat claims, evidence, and risks.
View AZN analysisCelsius Holdings, Inc.
CELH · NASDAQ
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Celsius Holdings, Inc.'s moat claims, evidence, and risks.
View CELH analysisComparison highlights
- Moat score gap: AstraZeneca PLC leads (71 / 100 vs 57 / 100 for Celsius Holdings, Inc.).
- Segment focus: AstraZeneca PLC has 6 segments (41% in Oncology); Celsius Holdings, Inc. has 1 segment (100% in Functional Energy Beverages (CELSIUS, Alani Nu, Rockstar)).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Strong vs Moderate.
- Moat breadth: AstraZeneca PLC has 4 moat types across 3 domains; Celsius Holdings, Inc. has 3 across 2.
Primary market context
AstraZeneca PLC
Oncology
Innovator oncology therapeutics (branded prescription medicines)
Global
Hospitals, oncology clinics, payers
Innovator biopharmaceutical company
41%
Celsius Holdings, Inc.
Functional Energy Beverages (CELSIUS, Alani Nu, Rockstar)
Energy drinks (functional/better-for-you positioning) and adjacent wellness products
Primarily North America; growing international presence
Consumers via retail and e-commerce channels; sold through distributor/retail channels
Brand owner / product developer; uses third-party manufacturing and third-party distribution
100%
Side-by-side metrics
Moat coverage
Shared moat types
AstraZeneca PLC strengths
Celsius Holdings, Inc. strengths
Segment mix
AstraZeneca PLC segments
Full profile >Oncology
Oligopoly
Cardiovascular, Renal and Metabolism (CVRM)
Competitive
Respiratory & Immunology (R&I)
Oligopoly
Vaccines & Immune Therapies (V&I)
Oligopoly
Rare Disease
Oligopoly
Other Medicines
Competitive
Celsius Holdings, Inc. segments
Full profile >Functional Energy Beverages (CELSIUS, Alani Nu, Rockstar)
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.